Isomeric Pharmacy Recalls Testosterone Injection Vials Due to Sterility Concerns
Isomeric Pharmacy Solution, LLC is recalling 2,156 vials of Testosterone Cypionate and Propionate injection due to production processes that cannot assure sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
Isomeric Pharmacy Solution, LLC is recalling 2,156 vials of Testosterone Cypionate 200 mg/mL, Testosterone Propionate 20 mg/mL, 30 mL Multi-Dose Vial For Injection. The recall was initiated because of concerns with production processes that cannot assure the sterility of products intended to be sterile.
The affected product is distributed nationwide in the USA and Puerto Rico. Specific lot numbers and expiration dates are listed in the recall notice, including lots 09018 through 12021 with expiration dates ranging from April 2017 to July 2017.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions. The FDA classifies this recall as Class II, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Testosterone Cypionate 200 mg/mL, Testosterone Propionate 20 mg/mL, 30 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1200, barcode 3 70285 12003 9.
- Manufacturer
- Isomeric Pharmacy Solution, LLC
- Category
- Drug — Injectable Steroids
- Affected units
- 2,156
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #s: 09018
- Exp 04/17/17
- 09023
- Exp 04/22/17
- 09024
- Exp 04/23/17
- 09027
- Exp 04/25/17
- 09031
- Exp 04/30/17
- 10005
- Exp 05/06/17
- 10010
- Exp 05/09/17
- 11022
- Exp 06/10/17
- 11038
- Exp 06/18/17
- 11044
- Exp 07/04/17
Distribution
Part of a larger recall action
This product is one of 7 recalled by Isomeric Pharmacy Solution, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Isomeric Pharmacy Solution, LLC
See all →- SevereIsomeric Pharmacy Recalls Methylprednisolone Acetate Injection Vials for Sterility Concerns
FDA (Drugs) · 2017-05-03
- SevereIsomeric Pharmacy Recalls Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2017-05-03
- SevereIsomeric Pharmacy Recalls Phenylephrine and Tropicamide Ophthalmic Drops
FDA (Drugs) · 2017-05-03
- SevereIsomeric Pharmacy Recalls Methylprednisolone Acetate Injection Vials for Sterility Concerns
FDA (Drugs) · 2017-05-03
- HighIsomeric Pharmacy Recalls Triamcinolone Diacetate Vials Due to Sterility Concerns
FDA (Drugs) · 2017-05-03
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTestosterone Cypionate/Propionate Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-10-06
- SevereTestosterone Cypionate Injection 200 mg/mL Recalled for Sterility Assurance
FDA (Drugs) · 2025-05-21
- SevereNew Vitalis Pharmacy Recalls Testosterone Injection Due to Sterility Concerns
FDA (Drugs) · 2019-12-04
- SevereTestosterone Cypionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SeverePharm D Solutions Recalls Testosterone Cypionate/Proprinate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07